Combined immunotherapy with whole tumor lysate-pulsed interleukin-15-activated dendritic cells and cucurbitacin I promotes strong CD8(+) T-cell responses and cures highly aggressive lymphoma. [electronic resource]
Producer: 20160328Description: 647-64 p. digitalISSN:- 1477-2566
- Animals
- Antioxidants -- metabolism
- Blood Glucose -- metabolism
- CD4-Positive T-Lymphocytes -- drug effects
- CD8-Positive T-Lymphocytes -- drug effects
- Cell Extracts -- therapeutic use
- Cell Proliferation -- drug effects
- Cytokines -- metabolism
- Cytotoxicity, Immunologic -- drug effects
- Dendritic Cells -- drug effects
- Immunotherapy
- Interleukin-15 -- pharmacology
- Lymphoma -- immunology
- Mice, Inbred AKR
- Neoplasm Metastasis
- Organ Specificity -- drug effects
- Remission Induction
- Survival Analysis
- TNF-Related Apoptosis-Inducing Ligand -- metabolism
- Triterpenes -- pharmacology
- Tumor Necrosis Factor-alpha -- metabolism
- Vaccination
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.